Paper Details

  1. Home
  2. Paper Details

The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).

Author: BeehKai-Michael, BjermerLeif, DeromEric, Echave-SustaetaJosé, GrönkeLars, HamiltonAlan, ZhaiDongmei

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Tiotropium plus olodaterol, taken once daily, has shown benefits beyond just lung function for people with COPD, potentially making it a good option for initial treatment. While guidelines recommend combining long-acting beta-agonists and inhaled corticosteroids only for people at high risk of exacerbations, they are often used for those at lower risk. This study aims to compare the effectiveness of this combination therapy with other combination treatments for people at lower risk of COPD exacerbations.
Paper Details　
Original Abstract of the Article :
Tiotropium + olodaterol has demonstrated improvements beyond lung function benefits in a large Phase III clinical program as a once-daily maintenance treatment for COPD and may be a potential option for the initiation of maintenance treatment in COPD. Despite guideline recommendations that combined ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745834/

データ提供：米国国立医学図書館（NLM）

The Power of Once-Daily Tiotropium and Olodaterol for COPD Management

The study investigates the effectiveness of a [once-daily combination therapy] for [COPD] using [tiotropium and olodaterol]. The authors compared this treatment to a [twice-daily combination therapy] using [salmeterol and fluticasone propionate]. Their findings demonstrate that the [once-daily combination therapy] offers superior [lung function] benefits, simplifying the treatment regimen for patients with [COPD].

Simplifying Treatment for COPD

The study highlights the potential of [once-daily combination therapy] in improving [COPD] management. The authors emphasize the convenience and effectiveness of the [tiotropium and olodaterol] combination, offering a simpler and more convenient treatment option for patients with [COPD].

Enhancing COPD Management

This research underscores the importance of exploring alternative treatment options for [COPD]. The findings suggest that [once-daily combination therapy] using [tiotropium and olodaterol] may be a valuable addition to the [COPD] treatment arsenal.

Dr. Camel's Conclusion

This study is like discovering a shortcut across the vast desert of [COPD] treatment! The authors demonstrate the potential of a [once-daily combination therapy] using [tiotropium and olodaterol] to simplify the treatment process for patients with [COPD]. This research highlights the importance of innovation and finding more convenient and effective ways to manage [COPD].

Date :
  1. Date Completed 2016-10-07
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

26893551

DOI: Digital Object Identifier

PMC4745834

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.